Opthea Ltd (OPT) - Net Assets

Latest as of June 2025: AU$-200.16 Million AUD ≈ $-141.63 Million USD

Based on the latest financial reports, Opthea Ltd (OPT) has net assets worth AU$-200.16 Million AUD (≈ $-141.63 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$56.54 Million ≈ $40.01 Million USD) and total liabilities (AU$256.70 Million ≈ $181.63 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check OPT financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-200.16 Million
% of Total Assets -354.0%
Annual Growth Rate N/A
5-Year Change -211.58%
10-Year Change -1442.42%
Growth Volatility 68.87

Opthea Ltd - Net Assets Trend (1989–2025)

This chart illustrates how Opthea Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Opthea Ltd total assets for the complete picture of this company's asset base.

Annual Net Assets for Opthea Ltd (1989–2025)

The table below shows the annual net assets of Opthea Ltd from 1989 to 2025. For live valuation and market cap data, see Opthea Ltd market capitalisation.

Year Net Assets Change
2025-06-30 AU$-201.07 Million
≈ $-142.27 Million		 -165.23%
2024-06-30 AU$-75.81 Million
≈ $-53.64 Million		 -762.15%
2023-06-30 AU$-8.79 Million
≈ $-6.22 Million		 -112.60%
2022-06-30 AU$69.77 Million
≈ $49.37 Million		 -61.28%
2021-06-30 AU$180.20 Million
≈ $127.50 Million		 +178.05%
2020-06-30 AU$64.81 Million
≈ $45.86 Million		 +108.26%
2019-06-30 AU$31.12 Million
≈ $22.02 Million		 -18.48%
2018-06-30 AU$38.17 Million
≈ $27.01 Million		 -29.95%
2017-06-30 AU$54.49 Million
≈ $38.56 Million		 +263.81%
2016-06-30 AU$14.98 Million
≈ $10.60 Million		 -10.10%
2015-06-30 AU$16.66 Million
≈ $11.79 Million		 +68.86%
2014-06-30 AU$9.87 Million
≈ $6.98 Million		 -24.71%
2013-06-30 AU$13.10 Million
≈ $9.27 Million		 -36.60%
2012-06-30 AU$20.67 Million
≈ $14.62 Million		 -11.39%
2011-06-30 AU$23.32 Million
≈ $16.50 Million		 -13.75%
2010-06-30 AU$27.04 Million
≈ $19.13 Million		 -13.58%
2009-06-30 AU$31.29 Million
≈ $22.14 Million		 -36.38%
2008-06-30 AU$49.18 Million
≈ $34.80 Million		 -4.88%
2007-06-30 AU$51.71 Million
≈ $36.59 Million		 +22.92%
2006-06-30 AU$42.07 Million
≈ $29.77 Million		 +46.94%
2005-06-30 AU$28.63 Million
≈ $20.26 Million		 -1.79%
2004-06-30 AU$29.15 Million
≈ $20.63 Million		 +18.92%
2003-06-30 AU$24.51 Million
≈ $17.35 Million		 +5.31%
2002-06-30 AU$23.28 Million
≈ $16.47 Million		 -3.81%
2001-06-30 AU$24.20 Million
≈ $17.12 Million		 +61.35%
2000-06-30 AU$15.00 Million
≈ $10.61 Million		 +109.61%
1999-06-30 AU$7.16 Million
≈ $5.06 Million		 +65.29%
1998-06-30 AU$4.33 Million
≈ $3.06 Million		 -18.68%
1997-06-30 AU$5.32 Million
≈ $3.77 Million		 +38.84%
1996-06-30 AU$3.83 Million
≈ $2.71 Million		 +84.90%
1995-06-30 AU$2.07 Million
≈ $1.47 Million		 -0.94%
1994-06-30 AU$2.09 Million
≈ $1.48 Million		 +29.55%
1993-06-30 AU$1.62 Million
≈ $1.14 Million		 -0.86%
1992-06-30 AU$1.63 Million
≈ $1.15 Million		 +26.06%
1991-06-30 AU$1.29 Million
≈ $914.88K		 -14.11%
1990-06-30 AU$1.51 Million
≈ $1.07 Million		 -37.55%
1989-06-30 AU$2.41 Million
≈ $1.71 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Opthea Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 74245573990.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$497.49 Million %
Other Comprehensive Income AU$43.94 Million %
Total Equity AU$-201.07 Million 100.00%

Opthea Ltd Competitors by Market Cap

The table below lists competitors of Opthea Ltd ranked by their market capitalization.

Company Market Cap
Anhui Wantong Technology Co Ltd
SHE:002331
 $581.16 Million
TTY Biopharm Co Ltd
TWO:4105
 $581.27 Million
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
 $581.45 Million
Beijing Quanshi World Online Net
SHE:002995
 $581.66 Million
Audax Renovables S.A.
MC:ADX
 $580.70 Million
DXN HOLDINGS BHD.
KLSE:5318
 $580.49 Million
UE Furniture Co Ltd
SHG:603600
 $580.23 Million
Jinhua Chunguang Technology Co Ltd
SHG:603657
 $580.22 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Opthea Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -75,810,077 to -201,069,000, a change of -125,258,923.
  • Net loss of 162,791,000 reduced equity.
  • Share repurchases of 34,860,000 reduced equity.
  • New share issuances of 34,809,000 increased equity.
  • Other comprehensive income increased equity by 6,127,679.
  • Other factors increased equity by 31,455,398.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-162.79 Million -80.96%
Share Repurchases AU$34.86 Million -17.34%
Share Issuances AU$34.81 Million +17.31%
Other Comprehensive Income AU$6.13 Million +3.05%
Other Changes AU$31.46 Million +15.64%
Total Change AU$- %

Book Value vs Market Value Analysis

This analysis compares Opthea Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-06-30 AU$0.01 AU$0.60 x
1990-06-30 AU$0.01 AU$0.60 x
1991-06-30 AU$0.01 AU$0.60 x
1992-06-30 AU$0.01 AU$0.60 x
1993-06-30 AU$0.01 AU$0.60 x
1994-06-30 AU$0.02 AU$0.60 x
1995-06-30 AU$0.02 AU$0.60 x
1996-06-30 AU$0.03 AU$0.60 x
1997-06-30 AU$0.14 AU$0.60 x
1998-06-30 AU$0.12 AU$0.60 x
1999-06-30 AU$0.21 AU$0.60 x
2000-06-30 AU$0.42 AU$0.60 x
2001-06-30 AU$0.57 AU$0.60 x
2002-06-30 AU$0.52 AU$0.60 x
2003-06-30 AU$0.55 AU$0.60 x
2004-06-30 AU$0.62 AU$0.60 x
2005-06-30 AU$0.60 AU$0.60 x
2006-06-30 AU$0.96 AU$0.60 x
2007-06-30 AU$1.00 AU$0.60 x
2008-06-30 AU$0.96 AU$0.60 x
2009-06-30 AU$0.65 AU$0.60 x
2010-06-30 AU$0.55 AU$0.60 x
2011-06-30 AU$0.46 AU$0.60 x
2012-06-30 AU$0.38 AU$0.60 x
2013-06-30 AU$0.25 AU$0.60 x
2014-06-30 AU$0.17 AU$0.60 x
2015-06-30 AU$0.14 AU$0.60 x
2016-06-30 AU$0.09 AU$0.60 x
2017-06-30 AU$0.29 AU$0.60 x
2018-06-30 AU$0.16 AU$0.60 x
2019-06-30 AU$0.13 AU$0.60 x
2020-06-30 AU$0.25 AU$0.60 x
2021-06-30 AU$0.53 AU$0.60 x
2022-06-30 AU$0.19 AU$0.60 x
2023-06-30 AU$-0.02 AU$0.60 x
2024-06-30 AU$-0.12 AU$0.60 x
2025-06-30 AU$-0.16 AU$0.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Opthea Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -651164.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-19.81%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1989 -16.79% 0.00% 0.00x 1.00x AU$-655.34K
1990 -32.72% 0.00% 0.00x 1.02x AU$-643.12K
1991 -10.54% 0.00% 0.00x 1.00x AU$-270.49K
1992 -3.67% 0.00% 0.00x 1.01x AU$-225.29K
1993 -20.99% 0.00% 0.00x 1.01x AU$-504.00K
1994 -2.16% 0.00% 0.00x 1.01x AU$-255.23K
1995 -22.77% 0.00% 0.00x 1.03x AU$-679.73K
1996 -22.39% 0.00% 0.00x 1.03x AU$-1.24 Million
1997 -19.79% -438.08% 0.04x 1.03x AU$-1.59 Million
1998 -28.41% -638.09% 0.04x 1.04x AU$-1.66 Million
1999 22.11% 0.05% 402.69x 1.02x AU$866.71K
2000 4.87% 27.87% 0.17x 1.01x AU$-769.50K
2001 -3.34% -50.45% 0.07x 1.02x AU$-3.20 Million
2002 -13.89% -33785.77% 0.00x 1.01x AU$-5.56 Million
2003 -9.64% -274.11% 0.03x 1.01x AU$-4.81 Million
2004 13.92% 33157.78% 0.00x 1.01x AU$1.14 Million
2005 58.20% 124404.80% 0.00x 1.15x AU$13.75 Million
2006 -11.44% -437.02% 0.03x 1.04x AU$-9.00 Million
2007 20.06% 49675.59% 0.00x 1.20x AU$4.77 Million
2008 -2.42% -7652.13% 0.00x 1.14x AU$-5.64 Million
2009 -25.59% -337.69% 0.07x 1.07x AU$-11.13 Million
2010 -21.84% -359.19% 0.06x 1.09x AU$-8.61 Million
2011 -47.04% 0.00% 0.00x 1.12x AU$-13.30 Million
2012 -25.58% 0.00% 0.00x 1.20x AU$-6.89 Million
2013 -35.35% 0.00% 0.00x 1.22x AU$-5.57 Million
2014 -41.91% -475.61% 0.07x 1.31x AU$-4.66 Million
2015 -25.41% -433.90% 0.05x 1.15x AU$-5.68 Million
2016 -43.45% -850.34% 0.04x 1.14x AU$-8.01 Million
2017 -11.36% -1079.99% 0.01x 1.04x AU$-11.64 Million
2018 -44.28% -1477.70% 0.02x 1.21x AU$-20.72 Million
2019 -67.19% -18587.22% 0.00x 1.21x AU$-24.02 Million
2020 -24.87% -11047.04% 0.00x 1.11x AU$-22.60 Million
2021 -33.73% -66087.58% 0.00x 1.02x AU$-78.81 Million
2022 -183.45% -102353.69% 0.00x 1.25x AU$-134.97 Million
2023 0.00% -131469.80% 0.00x 0.00x AU$-211.00 Million
2024 0.00% -176665.73% 0.00x 0.00x AU$-212.66 Million
2025 0.00% -651164.00% 0.00x 0.00x AU$-142.68 Million

Industry Comparison

This section compares Opthea Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $11,537,405
  • Average return on equity (ROE) among peers: -124.60%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Opthea Ltd (OPT) AU$-200.16 Million -16.79% N/A $580.76 Million
Adalta Ltd (1AD) $172.82K -722.64% 1.66x $8.12 Million
Algorae Pharmaceuticals Ltd (1AI) $8.43 Million -80.40% 0.15x $20.04 Million
ACRUX Ltd (ACR) $43.92 Million -0.55% 0.08x $3.49 Million
Actinogen Medical Ltd (ACW) $21.74 Million -43.69% 0.07x $103.45 Million
Argenica Therapeutics Ltd (AGN) $8.31 Million -49.24% 0.09x $15.45 Million
Arovella Therapeutics Ltd (ALA) $19.30 Million -17.45% 0.18x $66.62 Million
Anatara Lifesciences Ltd (ANR) $5.92 Million -48.49% 0.08x $1.57 Million
Alterity Therapeutics Ltd (ATH) $-80.67K 0.00% 0.00x $80.80 Million
Amplia Therapeutics Ltd (ATX) $6.07 Million -40.21% 0.29x $54.45 Million
Avecho Biotechnology Ltd (AVE) $1.59 Million -243.30% 0.02x $31.19 Million

About Opthea Ltd

AU:OPT Australia Biotechnology
Market Cap
$580.76 Million
AU$820.79 Million AUD
Market Cap Rank
#11786 Global
#295 in Australia
Share Price
AU$0.60
Change (1 day)
+0.00%
52-Week Range
AU$0.60 - AU$0.60
All Time High
AU$3.47
Categories
Companies in Australia Biotechnology
About

Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME).… Read more